GlobeNewswire 2021-05-06 ObsEva Announces First Quarter 2021 Financial Results and Business Update
GlobeNewswire 2021-05-06 ObsEva appoints Clive Bertram as Chief Commercial Officer
GlobeNewswire 2021-05-04 ObsEva Announces Enrollment Completion of Linzagolix Phase 3 EDELWEISS 3 Trial for Patients with Mod...
GlobeNewswire 2021-04-30 ObsEva SA presents posters at the ACOG Annual Clinical and Scientific Virtual Meeting April 30 - May...
GlobeNewswire 2021-04-27 ObsEva Initiates PRIMROSE 3 Bone Mineral Density Follow-Up Study in PRIMROSE 1 and PRIMROSE 2 Trial ...
GlobeNewswire 2021-04-22 ObsEva Annual General Meeting 2021
GlobeNewswire 2021-03-05 ObsEva Announces Year End 2020 Financial Results and Business Update
GlobeNewswire 2021-03-03 ObsEva to Present at the H.C. Wainwright Global Life Sciences Conference
GlobeNewswire 2021-02-17 ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference
GlobeNewswire 2021-02-11 ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
GlobeNewswire 2021-02-10 ObsEva Provides Business Outlook for 2021
GlobeNewswire 2021-01-28 ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
GlobeNewswire 2021-01-11 ObsEva Provides Update on Yselty® (Linzagolix) Clinical Development Program
GlobeNewswire 2021-01-07 ObsEva SA to Participate in JP Morgan Virtual Healthcare Conference January 11 - 14, 2021
GlobeNewswire 2021-01-04 ObsEva appoints David Renas as Chief Financial Officer
GlobeNewswire 2020-12-10 ObsEva Announces Additional Phase 3 PRIMROSE 1 and 2 Study Results Confirming Sustained Efficacy and...
GlobeNewswire 2020-12-01 ObsEva SA to present at The International Society of Gynecological Endocrinology 19th World Congress...
GlobeNewswire 2020-11-24 ObsEva SA Submits Marketing Authorization Application to the European Medicines Agency for YSELTY® (...
GlobeNewswire 2020-11-16 ObsEva SA Reports Positive Topline Results of the PROLONG Proof-of-Concept Trial of Ebopiprant (OBE0...
GlobeNewswire 2020-11-13 ObsEva SA to present at Jefferies Virtual London Healthcare Conference, November 17 – 19, 2020
GlobeNewswire 2020-11-09 ObsEva appoints Brian O’Callaghan as Chief Executive Officer
GlobeNewswire 2020-11-06 Atea Pharmaceuticals Expands Board of Directors with Appointment of Barbara Duncan
GlobeNewswire 2020-11-05 ObsEva Announces Third Quarter 2020 Financial Results and Business Update
GlobeNewswire 2020-11-02 ObsEva SA hosts live symposium and presents oral communication at the SEUD Online Week November 3 - ...
GlobeNewswire 2020-10-22 ObsEva SA Presented Two Late-Breaking Posters at the ASRM 2020 Virtual Scientific Congress October 1...